Biosite(R) Incorporated to Conduct 2nd Quarter Results Conference Call

Biosite(R) Incorporated to Conduct 2nd Quarter Results Conference
Call 


SAN DIEGO, July 14  /PRNewswire-FirstCall/ -- Biosite Incorporated
(NASDAQ:BSTE) announces the following Webcast:

Biosite Incorporated will announce 2005 second quarter results on Tuesday, July
26, 2005 following the close of the market.  The Company will also webcast a
conference call on the same day (July 26) at 1:30 p.m. Pacific.

   What:          Biosite Announces 2nd Quarter Results Conference Call

   When:          Tuesday, July 26, 2005 at 1:30 p.m. Pacific



Where:         http://phx.corporate-ir.net/phoenix.zhtml?p=irol-
eventDetails&c=69046&eventID=1100191

                  OR http://www.biosite.com/

   How:           Live over the Internet -- Simply log onto the web at the
                  address above.

   Telephonic:    US/Canada/Int'l Dial #: [phone]
                  Conference ID# 7772745

                  You may dial *0 at any time for Operator assistance

   Contact:       Simona Dixon
                  Corporate and Investor Relations
                  Biosite Incorporated
                  858.455.4808 ext. 3221
                  email: 



If you are unable to participate during the live webcast, the call will be
archived on the Biosite web site http://www.biosite.com/ until August 16th,
2005. The telephone replay number for U.S. callers is 800-642-1687. 
International callers can dial 706-645-9291, conference ID# 7772745.

Company press releases may be found at http://www.biosite.com/

About Biosite: A leader in the drive to advance diagnosis, Biosite Incorporated
is a research-based company dedicated to the discovery and development of novel
protein-based diagnostic tests that improve a physician's ability to diagnose
debilitating and life-threatening diseases.  The Company combines integrated
discovery and diagnostics businesses to access proteomics research, identify
proteins with high diagnostic utility, develop and commercialize products and
educate the medical community on new diagnostic approaches that improve health
care outcomes.  Biosite's Triage(R) brand rapid diagnostic tests are used in
approximately 50 percent of U.S. hospitals and in more than 50 international
markets. Biosite's commercialized products include the Triage BNP Test to aid
in the diagnosis and severity assessment of heart failure, the Triage Cardiac
Panel to aid in the diagnosis of heart attacks and the Triage Drugs of Abuse
Products for the diagnosis of drug overdose. These tests can deliver critical
diagnostic information to physicians within 10 to 20 minutes.  Information
about Biosite can be found at http://www.biosite.com/.

(Minimum Requirements to listen to broadcast:  The Windows Media Player
software, downloadable free from:
http://www.microsoft.com/windows/windowsmedia/EN/default.asp and at least a
28.8Kbps connection to the Internet.) 

DATASOURCE: Biosite Incorporated



CONTACT:  Nadine Padilla, VP, Corporate & Investor Relations of Biosite

Incorporated, [phone], ext. 3187, 



Web site:  http://www.biosite.com/



Company News On-Call:  http://www.prnewswire.com/comp/116737.html 

Copyright